Dedicated post-treatment monitoring and specialized maintenance protocols focused on proactive surveillance and the long-term health of your lymphatic system

Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis. 

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Survivorship and Monitoring

Survivorship and Monitoring

Completing lymphoma treatment marks the transition to survivorship. The primary goal of maintenance care is to monitor for disease recurrence while managing the long-term physical and psychological effects of cancer therapy. For the first two years, follow-up visits are frequent, typically every 3 to 6 months, as this is the period when relapse is most likely to occur. These visits involve physical exams to check for swollen nodes and blood tests.

Routine imaging (CT or PET scans) in asymptomatic patients is becoming less common for many subtypes (like DLBCL) once remission is confirmed. Evidence suggests that recurrence is most often detected by the patient noticing symptoms rather than by routine scans. Therefore, patient education on reporting new lumps, fevers, or night sweats is the most effective surveillance tool. For indolent lymphomas, which are chronic, surveillance may continue indefinitely.

Survivorship plans summarize the treatment received (total radiation dose, cumulative chemotherapy drugs) and outline the specific screening needs for the future. This “health passport” is crucial for coordinating care between the oncologist and the primary care physician, ensuring that long-term risks are not overlooked as the patient moves further away from their acute cancer treatment.

  • Recurrence risk is highest in the first two years post-treatment.
  • Surveillance relies heavily on physical exams and symptom reporting.
  • Routine scanning is minimized to reduce radiation exposure and anxiety.
  • Survivorship care plans facilitate communication with primary care.
  • Indolent lymphomas require lifelong chronic disease monitoring.
Icon LIV Hospital

Late Effects: Cardiac and Pulmonary Health

Late Effects: Cardiac and Pulmonary Health

The curative therapies for lymphoma can leave a lasting imprint on organ function. Cardiotoxicity is a significant concern for patients treated with anthracyclines (Doxorubicin), which can weaken the heart muscle, leading to cardiomyopathy or congestive heart failure years or decades later. Radiation to the chest also increases the risk of coronary artery disease and valve damage. Survivors need aggressive management of cardiovascular risk factors (blood pressure, cholesterol) and may require periodic echocardiograms.

Pulmonary health is critical for patients treated with Bleomycin (used in Hodgkin Lymphoma) or chest radiation. Bleomycin can cause lung scarring (fibrosis). Survivors are advised to avoid smoking and may need to be cautious with high concentrations of oxygen (e.g., during future surgeries or scuba diving), which can exacerbate lung damage. Pulmonary function tests may be used to monitor lung capacity.

Survivors should also be aware of the increased risk of metabolic syndrome. Chemotherapy and steroid use can lead to long-term changes in metabolism, increasing the risk of diabetes and obesity. A heart-healthy diet and regular exercise are not just general advice but specific medical interventions to mitigate these iatrogenic risks.

  • Anthracyclines carry a lifetime risk of dose-dependent heart failure.
  • Chest radiation accelerates coronary artery disease and valve fibrosis.
  • Bleomycin toxicity requires lifelong pulmonary vigilance.
  • Smoking cessation is mandatory to preserve compromised lung function.
  • Metabolic health requires proactive management to protect the heart.
Icon 1 LIV Hospital

Secondary Malignancies

One of the most paradoxical risks of cancer treatment is the development of a new, unrelated cancer caused by the treatment itself. Chemotherapy and radiation damage DNA; occasionally, this damage affects healthy cells, leading to a secondary malignancy years later.

For lymphoma survivors, secondary leukemia (such as Acute Myeloid Leukemia or Myelodysplastic Syndrome) is a rare but serious risk associated with alkylating agents and etoposide. This typically occurs within the first decade after treatment. Solid tumors are also a risk, particularly in the radiation field. For example, young women treated with chest radiation for Hodgkin Lymphoma have a significantly increased risk of breast cancer later in life.

Screening protocols are adjusted to address these risks. Women who received chest radiation before age 30 often begin breast cancer screening (mammograms and MRI) much earlier than the general population, typically 8 to 10 years after treatment. Similarly, skin cancer screening and vigilant general cancer screening are emphasized for all survivors.

  • Treatment-induced DNA damage can cause secondary cancers.
  • Secondary leukemia is a rare risk of alkylating chemotherapy.
  • Chest radiation increases breast cancer risk in young female survivors.
  • Screening for secondary tumors begins earlier than standard guidelines.
  • Vigilance is required for tumors within prior radiation fields.

Infection Prevention and Immunosuppression

Infection Prevention and Immunosuppression

Lymphoma patients often remain immunocompromised for months or years after treatment ends. Treatments like Rituximab deplete B cells, reducing the body’s ability to make antibodies. This can lead to hypogammaglobulinemia (low antibody levels), making survivors more susceptible to recurrent sinus and lung infections.

Vaccination is a key component of maintenance, but timing is critical. Vaccines are generally not effective during B-cell depletion. Survivors are typically advised to receive the inactivated influenza vaccine annually and the pneumonia vaccine. Live virus vaccines (like Measles/Mumps/Rubella or Yellow Fever) are generally avoided or used with extreme caution in immunocompromised hosts.

Reactivation of dormant viruses is another concern. Patients with a history of Hepatitis B must take preventative antiviral medication during Rituximab therapy to prevent liver failure. Herpes zoster (shingles) is also more common, and vaccination (Shingrix) is recommended once the immune system has recovered sufficiently.

  • B-cell depletion leads to long-term reduction in antibody production.
  • Hypogammaglobulinemia increases susceptibility to bacterial infections.
  • Vaccination schedules must be adjusted for immune recovery status.
  • Live vaccines are contraindicated in patients with severe immunosuppression.
  • Hepatitis B reactivation requires prophylactic antiviral management.

Psychosocial Support and “Scanxiety”

Psychosocial Support and “Scanxiety”

The emotional toll of lymphoma extends well beyond physical remission. Many survivors struggle with “scanxiety”—the intense distress and fear leading up to and following routine follow-up scans. The fear of relapse can be paralyzing, making it difficult to plan for the future. Post Traumatic Stress Disorder (PTSD) symptoms are not uncommon, particularly in young adults whose lives were interrupted by the diagnosis.

Reintegration into work and social life can be challenging. Fatigue often persists long after treatment ends (“cancer-related fatigue”), impacting productivity and social energy. Patients may also struggle with “chemo brain,” mild cognitive impairments affecting memory and concentration.

Support groups and psycho oncology services provide vital tools for coping. Cognitive Behavioral Therapy (CBT) can help manage anxiety and sleep disturbances. Validating these experiences as standard parts of survivorship helps patients transition from the “patient” identity back to their personhood. Fertility preservation (sperm banking or egg freezing) discussions before treatment also play a role in long-term psychological well-being, offering hope for future family building.

  • “Scanxiety” is a prevalent physiological response to follow-up testing.
  • Fear of recurrence impacts long-term mental health.
  • Cancer-related fatigue and “chemo brain” affect daily functioning.
  • Cognitive Behavioral Therapy aids in managing survivorship anxiety.
  • Fertility preservation supports future life planning and hope.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches
Group 346 LIV Hospital

Reviews from 9,651

4,9

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

What is the “Look Good Feel Better” program?

Many cancer centers offer programs like this to help patients manage the visible side effects of treatment. They provide workshops on skin care, wig styling, and makeup techniques to help manage changes in appearance (like loss of eyebrows or eyelashes), which can significantly boost self-esteem and social confidence during recovery.

Yes, massage is generally safe and beneficial for reducing stress and muscle tension. However, if you have had lymph nodes removed or radiation, you should see a therapist trained in “oncology massage.” They know to avoid deep pressure in areas at risk for lymphedema and to be gentle with fragile skin or bone.

Chemo brain refers to the mental fog, memory lapses, and difficulty concentrating that some patients experience during and after chemotherapy. While usually temporary, improving over a year can be frustrating. Keeping lists, doing brain puzzles, and getting enough sleep can help manage the symptoms.

Always consult your oncologist before taking supplements. Some vitamins or antioxidants can interfere with how chemotherapy or radiation works. “Immune boosting” supplements can sometimes be harmful or ineffective. The best way to support your immune system is through a balanced diet, hygiene, and recommended vaccines.

If lymph nodes are surgically removed or damaged by radiation, the flow of lymph fluid can be blocked, leading to swelling in the arm or leg. This is called lymphedema. It is a chronic condition, but can be managed with compression garments, specialized massage (lymphatic drainage), and skin care to prevent infection.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Let's Talk About Your Health

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

How helpful was it?

helpful
helpful
helpful
Your Comparison List (you must select at least 2 packages)